FINHUB Insights

ResMed Q1 FY26: where the revenue came from and where it went

The whole income statement of ResMed for this quarter, as one diagram: what earned the revenue, and what it went on.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 31, 2025 10-Q accession 0000943819-25-000090

Revenue$1.34B +9% year over year
Gross profit$0.82B 61% margin
Operating profit$0.45B 33% margin
Net profit$0.35B 26% margin
100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Already have an account? Sign in

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 1.34 100% +9%
Sleep & breathing health 1.17 88% +10%
Residential care software 0.17 12% +6%
Cost of revenue−0.5239%
Gross profit0.8261% margin+3pp
R&D−0.097%+0pp
SG&A−0.2619%+0pp
Other−0.032%+0pp
Operating profit0.4533% margin+2pp
Tax−0.10
Net profit0.35 26% margin+1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

51 of 418 companies, most recently reported first